Diploma (LON:DPLM - Get Free Report)'s stock had its "buy" rating reissued by Shore Capital in a report issued on Monday, Digital Look reports.
A number of other brokerages also recently issued reports on DPLM. Berenberg Bank upped their price target on Diploma from GBX 3,800 ($47.73) to GBX 4,400 ($55.26) and gave the company a "buy" rating in a report on Thursday, March 28th. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a GBX 4,500 ($56.52) price target on shares of Diploma in a report on Tuesday, May 7th. One investment analyst has rated the stock with a sell rating and four have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of GBX 3,712.50 ($46.63).
Check Out Our Latest Stock Analysis on DPLM
Diploma Stock Up 4.0 %
Shares of LON:DPLM traded up GBX 158 ($1.98) on Monday, hitting GBX 4,060 ($50.99). 504,770 shares of the company traded hands, compared to its average volume of 270,525. The company has a market cap of £5.44 billion, a PE ratio of 4,461.54, a PEG ratio of 2.82 and a beta of 0.73. Diploma has a 52 week low of GBX 2,772.88 ($34.83) and a 52 week high of GBX 4,340 ($54.51). The company has a quick ratio of 0.80, a current ratio of 2.06 and a debt-to-equity ratio of 44.05. The stock has a 50 day simple moving average of GBX 3,575.44 and a 200-day simple moving average of GBX 3,408.33.
About Diploma
(
Get Free Report)
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Diploma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list.
While Diploma currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
